Maraganore John (CIK 0001180432)

Latest company ownership

Shares held
49,457
Last filed at
May 17, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4
Shares held
28,528
Last filed at
Feb 3, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 21, 2021 Dec 23, 2021 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 92.5 +7,531 3.37% ✗ $1.3M
Nov 12, 2021 Nov 12, 2021 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 18.8 -33,978 -13.49% ✓ $5.8M
Aug 13, 2021 Aug 16, 2021 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 18.8 -33,979 -13.49% ✓ $6.8M
May 13, 2021 May 17, 2021 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 20.0 -33,979 -13.49% ✓ $4.4M
Apr 19, 2021 Apr 21, 2021 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 90.0 +8,729 4.17% ✗ $989.8K
Feb 25, 2021 Feb 26, 2021 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 18.8 -33,979 -13.97% ✓ $5M
Feb 11, 2021 Feb 16, 2021 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 90.0 +8,447 4.21% ✗ $890.9K
Nov 19, 2020 Nov 20, 2020 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 20.0 -34,765 -14.76% ✓ $4.3M
Aug 20, 2020 Aug 21, 2020 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 20.0 -34,765 -14.76% ✓ $4.7M
May 20, 2020 May 22, 2020 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 20.0 -34,765 -14.76% ✓ $5M
Apr 7, 2020 Apr 9, 2020 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 90.0 +7,596 3.93% ✗ $688.7K
Feb 20, 2020 Feb 21, 2020 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 15.0 -34,765 -15.26% ✓ $4.6M
Oct 14, 2019 Oct 16, 2019 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 10.0 -49,456 -20.39% ✓ $3.9M
May 15, 2019 May 17, 2019 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 10.0 -49,396 -20.37% ✓ $3.5M
Nov 21, 2018 Nov 26, 2018 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 37.5 -59,923 -23.69% ✗ $4.4M
Sep 11, 2018 Sep 13, 2018 AGIOS PHARMACEUTICALS, INC. Director Sell 17.5 -27,717 -55.70% ✗ $2M
Jul 25, 2018 Jul 27, 2018 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 8.8 -49,939 -24.45% ✓ $5.3M
Nov 22, 2017 Nov 24, 2017 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 3.8 -73,415 -32.47% ✓ $9.6M
Nov 15, 2017 Nov 17, 2017 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 3.8 -74,000 -32.65% ✓ $9.4M
Dec 12, 2016 Dec 14, 2016 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 40.0 -22,710 -13.06% ✗ $967.7K
Jul 19, 2016 Jul 21, 2016 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 32.5 -30,151 -4.20% ✓ $2M
Apr 19, 2016 Apr 21, 2016 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 32.5 -30,151 -4.26% ✓ $2M
Jan 19, 2016 Jan 21, 2016 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 40.0 -30,152 -1.26% ✓ $2.2M
Dec 2, 2015 Dec 4, 2015 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 3.8 -58,689 -30.12% ✓ $6.2M
Nov 20, 2015 Nov 20, 2015 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 3.8 -58,690 -30.12% ✓ $6M
Jan 26, 2015 Jan 28, 2015 ALNYLAM PHARMACEUTICALS, INC. CEO Buy 92.5 +10,000 8.66% ✗ $950K
May 23, 2014 Sep 19, 2014 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 18.8 -115,368 -10.46% ✓ $8.8M
Jun 25, 2014 Jun 27, 2014 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 13.8 -113,668 -16.48% ✓ $7.4M
May 14, 2014 May 16, 2014 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 8.8 -113,668 -20.15% ✓ $6.4M
Sep 11, 2013 Sep 12, 2013 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 5.0 -58,947 -73.53% ✓ $3.3M
Aug 14, 2013 Aug 16, 2013 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 5.0 -60,000 -73.87% ✓ $2.9M